SecBot SecBot
SECBOTREPLAY Home › Report › NRIX

NRIX · Christine Ring, an officer of Nurix Therapeutics, filed a Form 144…

Nurix Therapeutics, Inc. · 144 filed Nov 2, 2026 at 16:31 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 2, 2026 at 16:31 ET

Christine Ring, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 5,786 shares of common stock, valued at approximately $284,134 based on the filing date price. The shares were acquired through the exercise of stock options on November 2, 2026, and the sale is planned for the same day. The filing also discloses prior 10b5-1 plan sales in August, September, and October 2026, indicating a pattern of routine insider selling.

  • Christine Ring, an officer, filed Form 144 to sell 5,786 shares of common stock.
  • Estimated sale value is $284,133.60 based on the filing date.
  • Shares were acquired via exercise of stock options on November 2, 2026.
  • Proposed sale date is November 2, 2026 (same day as filing).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access